OrbiMed Capital GP III LLC

CIK 1432241 · last filed 2018-05-02

OrbiMed Capital GP III LLC is a corporate insider who has filed 23 SEC Form 4 insider transactions across 9 companies since 2011. The most recent filing shows the insider sold $12.7M of PIRS on May 2, 2018. Across all open-market trades the lifetime net is −$326.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $78.0M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$78.04M

Companies

9

Total Filings

23

Lifetime Open-Market Net

-$326.29M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PALVELLA THERAPEUTICS, INC. (PIRS) Delisted Director 4,511,130 $13.60 $61.35M -$8.57M 2 2018-05-02
GKOS Director 159,798 $126.81 $20.26M -$83.18M 3 2018-03-06
Roka BioScience, Inc. (ROKA) Delisted 10%+ Owner 796,311 $13.74M 2 2017-08-25
ViewRay, Inc. (VRAY) Delisted Director 86,107 $0.03 $2.2K $10.07M 1 2016-08-24
Cartesian Therapeutics, Inc. (SELB) Delisted Director 12,193 $0.88 $10.7K $23.10M 1 2016-06-29
Sientra, Inc. (SIEN) Delisted 10%+ Owner 17,100 $0.17 $3.0K -$18.13M 4 2015-10-13
AMBIT BIOSCIENCES CORP (AMBI) Delisted 10%+ Owner 7,424 $0.54 $4.0K $16.27M 1 2013-05-22
AMRN Director 5,700 $15.24 $86.9K -$287.49M 7 2012-09-05
PCRX 10%+ Owner 2,509,100 $22.99 $57.68M $7.91M 2 2012-03-13

Recent Filings

23 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2018-05-02 PALVELLA THERAPEUTICS, INC. (PIRS) Delisted Sell (S) −2,000,000 -$12.70M EDGAR
2018-03-06 GKOS Sell (S) −1,673,000 -$53.57M EDGAR
2017-08-25 Roka BioScience, Inc. (ROKA) Delisted Sell (S) −42,900 -$64.3K EDGAR
2016-08-24 ViewRay, Inc. (VRAY) Delisted Buy (P) +3,414,222 $10.07M EDGAR
2016-08-12 GKOS Sell (S) −878,814 -$29.61M EDGAR
2016-06-29 Cartesian Therapeutics, Inc. (SELB) Delisted Mixed +5,183,985 $23.10M EDGAR
2015-10-13 Sientra, Inc. (SIEN) Delisted Sell (S) −863,673 -$5.16M EDGAR
2015-10-06 Sientra, Inc. (SIEN) Delisted Sell (S) −579,000 -$5.04M EDGAR
2015-10-01 Sientra, Inc. (SIEN) Delisted Sell (S) −305,694 -$3.13M EDGAR
2015-09-28 Sientra, Inc. (SIEN) Delisted Sell (S) −452,724 -$4.79M EDGAR
Showing 110 of 23
Page 1 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.